|
Recommended citation: |
Download PDF: Complete Report, Executive Summary, Report, Appendices, Supplementary Materials
Among selected individuals with severely symptomatic chronic lumbar spinal stenosis (LSS) due to ligamentum flavum hypertrophy (LFH) who have not adequately responded to conventional medical management (CMM), Minimally Invasive Lumbar Decompression (MILD) may reduce pain severity and interference at 1 year versus CMM or epidural steroid injections (ESI) and may result in little to no difference versus laminectomy with spinal fusion. Data on procedural complications and subsequent procedures/surgeries are limited. Findings are limited by evidence quantity, quality, and applicability. There is no information from VHA medical centers, among individuals with less severe or shorter symptom duration, those undergoing repeat MILD, or whether effects vary by patient and spine characteristics or clinicians' training, experience, and volume. Long-term results are not known.
LSS is a common debilitating condition that can result in pain, dysfunction, and reduced life quality. Treatment for LSS includes anti-inflammatory and other medications, physical and manual therapy, and ESI. Unfortunately, randomized controlled trials (RCTs) have demonstrated their limited effectiveness. Decompressive laminectomy, with or without spinal fusion, requires surgery and recovery and has limited long-term effects. Additionally, patients may be unwilling or medically unsuitable for surgery. MILD, a new procedure for LSS secondary to LFH, is performed under indirect image guidance using specialized instruments for percutaneous limited laminectomy and thinning of the ligamentum flavum.
We identified 27 primary studies (4 RCTs, 3 controlled observational studies, and 20 uncontrolled case series/reports) evaluating MILD. Most studies were small and short term. Among individuals with severely symptomatic LSS due to LFH (>2.5 mm), MILD may improve pain and function at 1 year versus CMM (low certainty evidence); the comparative effect is modest. MILD may reduce pain severity and interference compared with ESI (low COE). Compared with lumbar decompression plus spinal fusion, MILD may have similar effects on pain and function (low COE) but the effects on harms and subsequent surgeries are very uncertain. Compared with interspinous spacers, evidence regarding subsequent surgeries is very uncertain but MILD may be associated with fewer adverse events. Uncontrolled studies suggest wide-ranging rates of subsequent surgery but few adverse events following MILD. RCTs evaluating MILD versus surgical laminectomy are needed as well as assessment of long-term durability and repeatability of MILD, and outcomes in those with less severe symptoms and treated by clinicians with less advanced MILD training/experience. Surveillance is needed to evaluate patient selection and clinician criteria, long-term effectiveness and harms, subsequent interventions, and cost effectiveness.
Percutaneous Image-Guided Lumbar Decompression: A Systematic Review of the Minimally Invasive Lumbar Decompression (MILD) Procedure (Management Brief)